The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient correlates of patient-provider communication and financial toxicity in Black and White patients with cancer.
 
Lauren Hamel
No Relationships to Disclose
 
David Dougherty
No Relationships to Disclose
 
Seongho Kim
No Relationships to Disclose
 
Elisabeth Heath
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Johnson & Johnson/Janssen; Sanofi; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Gilead Sciences; Novartis; Novartis; Sanofi
Speakers' Bureau - Sanofi
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Calibr (Inst); Calithera Biosciences (Inst); Caris Life Sciences (Inst); Corcept Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo Inc. (Inst); Eisai (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fortis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen Research & Development (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncolys BioPharma (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); POINT Biopharma (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Sanofi
Other Relationship - Caris Centers of Excellence
 
Lorna Mabunda
No Relationships to Disclose
 
Teneisha Austin
No Relationships to Disclose
 
Hadeel Assad
Honoraria - Gilead Sciences; Menarini
Consulting or Advisory Role - Daiichi Sankyo
Speakers' Bureau - Gilead Sciences; Stemline Therapeutics
 
Hirva Mamdani
Honoraria - Regeneron (I)
Consulting or Advisory Role - ADC Therapeutics (I); ADC Therapeutics (I); AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; Genmab (I)
Research Funding - AstraZeneca (Inst); Genentech (I); Genmab (I); Karyopharm Therapeutics (I)
Expert Testimony - AstraZeneca (I)
Travel, Accommodations, Expenses - AstraZeneca
 
Mohammed Al Hallak
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Exelixis; Guardant Health; Incyte; Pfizer; Takeda
 
Helda Bacall
No Relationships to Disclose
 
Adrienne Bouyer
No Relationships to Disclose
 
Frank Cackowski
Honoraria - GU Oncology Now, Mashup Media LLC
 
Radhika Gogoi
No Relationships to Disclose
 
Erica Goldman
No Relationships to Disclose
 
Ira Winer
Consulting or Advisory Role - GOG Partners
Research Funding - Jazz Pharmaceuticals (Inst); Oncoceutics (Inst)
Travel, Accommodations, Expenses - Regeneron
(OPTIONAL) Uncompensated Relationships - Ernexa Pharmaceuticals; Ernexa Pharmaceuticals
 
Eliza Beal
No Relationships to Disclose
 
Nouran Jarbo
No Relationships to Disclose
 
Keri Angers
No Relationships to Disclose
 
Susan Eggly
No Relationships to Disclose